What is the appropriate workup for proteinuria?

Workup for Proteinuria

Initial Confirmation and Quantification

Obtain a spot urine protein-to-creatinine ratio (UPCR) or albumin-to-creatinine ratio (ACR) on a first-morning void specimen to quantify proteinuria; do not rely on dipstick alone. 1

• Dipstick urinalysis is acceptable for initial screening, but any positive result (≥1+ or 30 mg/dL) must be confirmed with quantitative testing because dipstick measures concentration rather than total excretion and is highly susceptible to false positives from dilute/concentrated urine, hematuria, or alkaline pH. 1, 2

• For patients with diabetes or high CKD risk, use ACR (albumin-to-creatinine ratio) as the preferred test; for all other adults and children, UPCR (protein-to-creatinine ratio) is appropriate. 3, 1

• First-morning void is essential in children and young adults to exclude orthostatic (positional) proteinuria, which is benign; random specimens are acceptable in older adults. 3, 1

• Instruct patients to avoid vigorous exercise for 24 hours before collection, as physical activity causes transient elevation. 3, 1

Exclude Transient Causes Before Proceeding

Rule out and treat urinary tract infection, fever, marked hyperglycemia, severe hypertension, congestive heart failure, menstrual contamination, or recent strenuous exercise—all of which cause transient proteinuria—and repeat testing after resolution. 1, 4

Define Persistence

Persistent proteinuria requires two positive quantitative results out of three separate samples collected over 3 months; a single elevated value does not establish chronic kidney disease. 3, 1

• Normal thresholds: UPCR <200 mg/g (<0.2 mg/mg) or ACR <30 mg/g. 3, 1

• For diabetic patients with ACR ≥30 mg/g, confirm with 2 of 3 positive samples. 3

Baseline Laboratory Assessment

Once persistent proteinuria is confirmed, obtain:

• Serum creatinine and calculate eGFR using the CKD-EPI equation to stage kidney function and assess progression risk. 1, 2

• Urine sediment microscopy to detect dysmorphic red blood cells, red cell casts, or white cell casts—findings that indicate glomerular disease and mandate nephrology referral. 1

• Serum albumin if UPCR ≥3,500 mg/g (nephrotic range) to assess for hypoalbuminemia. 1

• Renal ultrasound in adults without diabetes to exclude structural abnormalities (polycystic kidney disease, hydronephrosis, asymmetric kidneys suggesting renovascular disease). 1

Risk Stratification by Proteinuria Level

Low-Level Proteinuria (UPCR 200–500 mg/g or ACR 30–299 mg/g)

• Annual monitoring with repeat UPCR/ACR and eGFR if patient has diabetes, hypertension, or family history of CKD. 1

• No immediate treatment required if blood pressure is normal and eGFR is stable. 1

Moderate Proteinuria (UPCR 500–1,000 mg/g or 0.5–1 g/day)

• Initiate ACE inhibitor or ARB therapy even if blood pressure is normal, as these agents reduce proteinuria independent of blood pressure lowering. 1

• Target blood pressure ≤130/80 mmHg. 1

• Implement dietary sodium restriction (<2 g/day) and protein restriction (~0.8 g/kg/day). 1

• Monitor serum creatinine and potassium 1–2 weeks after starting ACE-I/ARB to detect hyperkalemia or acute kidney injury. 1

• Reassess UPCR and eGFR every 6 months. 1

Significant Proteinuria (UPCR 1,000–3,500 mg/g or 1–3.5 g/day)

• Refer to nephrology if proteinuria persists >1 g/day after 3–6 months of optimized conservative therapy (ACE-I/ARB, sodium/protein restriction, blood pressure control). 1

• Target blood pressure <125/75 mmHg when proteinuria exceeds 1 g/day. 1

• Consider kidney biopsy if eGFR >50 mL/min/1.73 m² and proteinuria persists despite optimal medical management. 1

Nephrotic-Range Proteinuria (UPCR ≥3,500 mg/g or ≥3.5 g/day)

• Immediate nephrology referral is mandatory because of very high risk for progressive kidney disease, cardiovascular events, and thromboembolism. 1

• Kidney biopsy is typically required to identify the underlying glomerular pathology (membranous nephropathy, focal segmental glomerulosclerosis, minimal change disease) and guide immunosuppressive therapy. 1

• Confirm nephrotic syndrome with 24-hour urine collection (>3.5 g/day) if thromboprophylaxis decisions are needed. 1

Additional Nephrology Referral Criteria

Refer immediately if any of the following are present:

• eGFR <30 mL/min/1.73 m². 1

• Abrupt sustained ≥20% decline in eGFR after excluding reversible causes (volume depletion, medication changes). 1

• Active urinary sediment with dysmorphic RBCs or RBC casts. 1

• Proteinuria accompanied by hematuria. 1

• Uncertainty about etiology of kidney disease. 1

When to Use 24-Hour Urine Collection

Routine 24-hour collections are not recommended; spot UPCR provides equivalent accuracy and eliminates collection errors. 1, 2

Reserve 24-hour collection for:

• Confirming nephrotic-range proteinuria (>3.5 g/day) when thromboprophylaxis decisions are required. 1

• Establishing precise baseline before initiating immunosuppressive therapy for glomerular disease. 1

• Patients with extreme body habitus (cachexia, muscle atrophy, extreme obesity) where creatinine excretion is abnormal and spot ratios are unreliable. 3, 1

• Resolving discrepancies between spot UPCR and clinical presentation. 2

Common Pitfalls to Avoid

• Do not diagnose CKD based on a single dipstick or single quantitative test; persistence over 3 months must be documented. 1, 2

• Do not skip first-morning void collection in children and young adults; random specimens can falsely diagnose orthostatic proteinuria as pathologic. 3, 1

• Do not delay ACE-I/ARB therapy in patients with moderate-to-severe proteinuria while awaiting repeat testing; treatment should begin once persistence is confirmed. 1

• Do not order 24-hour collections routinely; they are cumbersome, frequently incomplete (~30% of attempts), and offer no advantage over spot UPCR for risk stratification. 1, 2

• Do not interpret serum creatinine as "normal" without calculating eGFR; a creatinine of 1.2 mg/dL in an elderly woman or person with low muscle mass often corresponds to eGFR 45–59 mL/min/1.73 m² (CKD stage 3a). 1

• Do not withhold ACE-I/ARB in patients with normal blood pressure and moderate proteinuria; renal protection is independent of blood pressure effects. 1